◍wovepaper
SearchResearchersInstitutions
Sign in
researcher

H. Dai

4 papers hereh-index 3207 citations9 works total

Matching runs newest-first, so older work may not be attached to this profile yet.

author position
  • sole author1
  • first author1
  • middle author2

Across the 4 of 4 papers where every author was matched, so the position is known.

fields
  • cs.AI1
  • cs.GT1
  • cs.LG1
  • q-bio.BM1
same name
  • H. Dai — 201 papers, h 34
  • H. Dai — 141 papers, h 44
  • H. Dai — 99 papers, h 7
  • H. Dai — 73 papers, h 9
  • H. Dai — 69 papers, h 6
  • H. Dai — 65 papers, h 138

Either other researchers who publish under this name, or the same person where the external sources have not merged their records.

identity via Semantic Scholar / OpenAlex

most citedA Survey of Generative AI for de novo Drug Design: New Frontiers in Molecule and Protein Generation

4 citations · 4 across the 3 of their papers we have counts for

collaborators

4 papers

cs.LG2025

A Graph Laplacian Eigenvector-based Pre-training Method for Graph Neural Networks

Howard Dai, Nyambura Njenga, Hiren Madhu +4

The development of self-supervised graph pre-training methods is a crucial ingredient in recent efforts to design robust graph foundation models (GFMs). Structure-based pre-trainin…

cs.GT2025

Polynomial Expectation Property for Max-Polymatrix Games

Howard Dai

We address an open problem on the computability of correlated equilibria in a variant of polymatrix where each player's utility is the maximum of their edge payoffs. We demonstrate…

cs.AI2025

Creativity or Brute Force? Using Brainteasers as a Window into the Problem-Solving Abilities of Large Language Models

Simeng Han, Howard Dai, Stephen Xia +7

Accuracy remains a standard metric for evaluating AI systems, but it offers limited insight into how models arrive at their solutions. In this work, we introduce a benchmark based…

q-bio.BM2024★ 4 cited

A Survey of Generative AI for de novo Drug Design: New Frontiers in Molecule and Protein Generation

Xiangru Tang, Howard Dai, Elizabeth Knight +4

Artificial intelligence (AI)-driven methods can vastly improve the historically costly drug design process, with various generative models already in widespread use. Generative mod…

◍wovepaper

Papers, researchers and institutions, woven together.

Explore
  • Search
  • Researchers
  • Institutions
Account
  • Library
  • Chat
Data
  • arXiv.org
  • Semantic Scholar
  • OpenAlex
  • Latest RSS
AboutContactPrivacyDevelopersllms.txtopenapi.json
Not affiliated with arXiv. Researcher data from Semantic Scholar (ODC-BY) and OpenAlex.